EMA’s Cancer ‘Pathfinder’ Project Targets Conditional Approvals, Endpoints & RWE

 
• By Ian Schofield
  
Cancer Diagnosis and disease detection or screening as a treatment for malignant cells with a biopsy or testing with a cancerous cell as an immunotherapy symbol
The EMA is targeting the development of drugs for cancer • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography